The board of the £752m Woodford Patient Capital Trust (WPCT) is proposing a number of changes to its investment objective, which would give manager Neil Woodford greater powers to keep pace with maturing companies in the portfolio.
The changes would allow the manager greater flexibility to use gearing and hold investments outside the UK, with fewer restrictions on the size of companies held and whether they are listed or unquoted....
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds